These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32301792)

  • 1. Neuromuscular Blockers in Acute Respiratory Distress Syndrome: Flat Dose or Not. Are We Missing the Point?
    Quintin L
    Crit Care Med; 2020 May; 48(5):e438. PubMed ID: 32301792
    [No Abstract]   [Full Text] [Related]  

  • 2. Sedation, Neuromuscular Blockade, and Mortality in Acute Respiratory Distress Syndrome: Important Questions Remain.
    Train SE; Dieffenbach PB; Massaro AF; Devlin JW
    Crit Care Med; 2022 Jan; 50(1):e89-e90. PubMed ID: 34914654
    [No Abstract]   [Full Text] [Related]  

  • 3. Rescue Neuromuscular Blockade in Acute Respiratory Distress Syndrome Should Not Be Flat Dose.
    Flannery AH; Moss M
    Crit Care Med; 2020 Apr; 48(4):588-590. PubMed ID: 32205606
    [No Abstract]   [Full Text] [Related]  

  • 4. Rescue Neuromuscular Blockade in Acute Respiratory Distress Syndrome Should Be Flat Dose.
    Co I; Hyzy RC
    Crit Care Med; 2020 Apr; 48(4):591-593. PubMed ID: 32205607
    [No Abstract]   [Full Text] [Related]  

  • 5. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    Gallo de Moraes A; El-Yafawi R; Oeckler RA
    N Engl J Med; 2019 Aug; 381(8):787. PubMed ID: 31433934
    [No Abstract]   [Full Text] [Related]  

  • 6. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    Aquino Esperanza J; de Haro C; Blanch L
    N Engl J Med; 2019 Aug; 381(8):785-786. PubMed ID: 31433932
    [No Abstract]   [Full Text] [Related]  

  • 7. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    Brink M; Everaars N; de Pont AJM
    N Engl J Med; 2019 Aug; 381(8):785. PubMed ID: 31433931
    [No Abstract]   [Full Text] [Related]  

  • 8. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome. Reply.
    Moss M; Ulysse CA; Angus DC;
    N Engl J Med; 2019 Aug; 381(8):787-788. PubMed ID: 31433935
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuromuscular Blockade Improves Results in Acute Respiratory Distress Syndrome: A Mechanism May Be Prevention of Expiratory Muscle Activity, Which Allows More Lung Expansion.
    de Vries HJ; Drummond G
    Am J Respir Crit Care Med; 2024 Mar; 209(5):478-481. PubMed ID: 38285592
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the use of neuromuscular blocking agents on acute respiratory distress syndrome outcomes: A systematic review.
    Paramore S
    J Am Assoc Nurse Pract; 2018 Jun; 30(6):327-332. PubMed ID: 29878965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study.
    Courcelle R; Gaudry S; Serck N; Blonz G; Lascarrou JB; Grimaldi D;
    Crit Care; 2020 Jul; 24(1):446. PubMed ID: 32684169
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results?
    Torbic H; Krishnan S; Duggal A
    Crit Care; 2019 Sep; 23(1):305. PubMed ID: 31492197
    [No Abstract]   [Full Text] [Related]  

  • 13. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    Yoshida T; Kavanagh BP; Brochard L
    N Engl J Med; 2019 Aug; 381(8):786-787. PubMed ID: 31433933
    [No Abstract]   [Full Text] [Related]  

  • 14. Sedation and Neuromuscular Blockade in Acute Respiratory Distress Syndrome: A Step Toward Disentangling Best Practices.
    Jabaley CS
    Crit Care Med; 2021 Jul; 49(7):1211-1213. PubMed ID: 34135282
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuromuscular Blockade Applicability in Early Acute Respiratory Distress Syndrome.
    Hurford WE
    Anesthesiology; 2020 Jun; 132(6):1577-1584. PubMed ID: 32032097
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
    Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
    Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Markov computer simulation model of the economics of neuromuscular blockade in patients with acute respiratory distress syndrome.
    Macario A; Chow JL; Dexter F
    BMC Med Inform Decis Mak; 2006 Mar; 6():15. PubMed ID: 16539706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of Pharmacologic Paralysis in Acute Respiratory Distress Syndrome.
    Syed A; Kobzik A; Huang DT
    Semin Respir Crit Care Med; 2019 Feb; 40(1):101-113. PubMed ID: 31060092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Rationale of the Reevaluation of Systemic Early Neuromuscular Blockade Trial for Acute Respiratory Distress Syndrome.
    Huang DT; Angus DC; Moss M; Thompson BT; Ferguson ND; Ginde A; Gong MN; Gundel S; Hayden DL; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Liu KD; Talmor DS; Yealy DM;
    Ann Am Thorac Soc; 2017 Jan; 14(1):124-133. PubMed ID: 27779896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.